Kymera Therapeutics Inc (KYMR)

Mar 27, 2025

Swiss National Bank Buys 10,300 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Mar 27, 2025

Mar 21, 2025

Victory Capital Management Inc. Raises Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Mar 21, 2025

Mar 21, 2025

Charles Schwab Investment Management Inc. Increases Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Mar 21, 2025

Mar 21, 2025

Analyzing Big Cypress Acquisition (OTCMKTS:BCYP) and Kymera Therapeutics (NASDAQ:KYMR) - Defense World

Mar 21, 2025

Mar 18, 2025

Bank of New York Mellon Corp Has $5.11 Million Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Mar 18, 2025

Mar 15, 2025

Citigroup Begins Coverage on Kymera Therapeutics (NASDAQ:KYMR) - Defense World

Mar 15, 2025

Mar 14, 2025

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

Mar 14, 2025

Mar 13, 2025

Citigroup Initiates Coverage of Kymera Therapeutics (KYMR) with Buy Recommendation - Nasdaq

Mar 13, 2025

Mar 11, 2025

(KYMR) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 11, 2025

Mar 07, 2025

Why Kymera Therapeutics’ Stock is Making Waves - TipRanks

Mar 07, 2025

Mar 06, 2025

Kymera at TD Cowen Conference: Focus on Clinical Advancements By Investing.com - Investing.com UK

Mar 06, 2025

Mar 06, 2025

Don't Ignore The Insider Selling In Kymera Therapeutics - Simply Wall St

Mar 06, 2025

Mar 06, 2025

Time To Worry? Analysts Just Downgraded Their Kymera Therapeutics, Inc. (NASDAQ:KYMR) Outlook - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

What is B. Riley’s Forecast for KYMR FY2025 Earnings? - Defense World

Mar 06, 2025

Mar 05, 2025

A Guide To The Risks Of Investing In Kymera Therapeutics Inc (KYMR) - Knox Daily

Mar 05, 2025

Mar 05, 2025

New York State Common Retirement Fund Reduces Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Mar 05, 2025

Mar 05, 2025

Equities Analysts Offer Predictions for KYMR Q1 Earnings - Defense World

Mar 05, 2025

Mar 05, 2025

Financial Review: Kymera Therapeutics (NASDAQ:KYMR) vs. Cardiff Oncology (NASDAQ:CRDF) - Defense World

Mar 05, 2025

Mar 04, 2025

Kymera Therapeutics announces new performance-based stock plan By Investing.com - Investing.com Australia

Mar 04, 2025

Mar 03, 2025

Kymera Therapeutics COO sells $42,113 in stock By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics’ chief legal officer sells $68,239 in stock By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics CFO sells shares worth $214,219 By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics’ chief medical officer sells shares worth $174,785 By Investing.com - Investing.com Canada

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics CFO sells shares worth $214,219 - Investing.com India

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics’ chief medical officer sells shares worth $174,785 - Investing.com

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics COO sells $42,113 in stock - Investing.com

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics announces new performance-based stock plan - Investing.com India

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics Grants Performance Stock Units to Executives - TipRanks

Mar 03, 2025

Mar 03, 2025

Rhumbline Advisers Acquires 1,861 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Mar 03, 2025

Mar 03, 2025

Q3 Earnings Forecast for KYMR Issued By HC Wainwright - Defense World

Mar 03, 2025

Mar 03, 2025

Analysts Set Expectations for KYMR Q2 Earnings - Defense World

Mar 03, 2025

Mar 03, 2025

Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $60.00 - Defense World

Mar 03, 2025

Mar 01, 2025

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Annual Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St

Mar 01, 2025

Mar 01, 2025

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates - Yahoo Finance

Mar 01, 2025

Mar 01, 2025

Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $60.00 at HC Wainwright - MarketBeat

Mar 01, 2025

Feb 28, 2025

Kymera Therapeutics (NASDAQ:KYMR) Announces Earnings Results - MarketBeat

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics’ Earnings Call Highlights Progress and Challenges - TipRanks

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics (NASDAQ:KYMR) Stock Price Down 13.9% on Disappointing Earnings - MarketBeat

Feb 28, 2025

Feb 28, 2025

(KYMR) Trading Signals - Stock Traders Daily

Feb 28, 2025

Feb 28, 2025

Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus - TradingView

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics Inc (KYMR) Volatility Hits 9.22%: What Good Investors Need To Be Aware Of - Stocks Register

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics stock target cut to $54 by H.C. Wainwright - Investing.com Canada

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Decoding Kymera Therapeutics Inc (KYMR): A Strategic SWOT Insigh - GuruFocus.com

Feb 28, 2025

Feb 28, 2025

Demystifying Kymera Therapeutics: Insights From 6 Analyst Reviews - Benzinga

Feb 28, 2025

Feb 28, 2025

We're Not Very Worried About Kymera Therapeutics' (NASDAQ:KYMR) Cash Burn Rate - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics Inc (KYMR) Q4 2024 Earnings Call Highlights: Strategic Collaborations and ... - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics Inc (KYMR) Q4 2024 Earnings Call Highlights: Strategic Collaborations and ... By GuruFocus - Investing.com Canada

Feb 28, 2025

Feb 28, 2025

Kymera Therapeutics (NASDAQ:KYMR) Reaches New 52-Week Low After Earnings Miss - Defense World

Feb 28, 2025

Feb 27, 2025

Kymera Therapeutics Reports 2024 Financial Results and Pipeline Progress - TipRanks

Feb 27, 2025

Feb 27, 2025

Kymera stock hits 52-week low at $29.23 amid market challenges - Investing.com

Feb 27, 2025